Tablets & Capsules

TC0615

Issue link: https://www.e-digitaleditions.com/i/525960

Contents of this Issue

Navigation

Page 30 of 131

Tablets & Capsules Solid Dosage SourceBook June 2015 29 Catalent Who We Are Catalyst + Talent. Our name combines these ideas. Catalent is the global leader in development solutions and advanced drug delivery technologies, providing worldwide clinical and commercial supply capabilities for drugs, biologics and consumer health products. With over 80 years serving the industry, we have proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable product supply. We serve thousands of innovators, both established and emerging, in over 80 countries, including 83 of the top 100 pharmaceutical and 38 of the top 50 biotech marketers. Our team of over 1,000 scientists has supported nearly half of all innovative drug and biologic approvals since 2005, and we have more than 450 active development programs for new customer products. 20 R&D teams in 10 countries help develop better treatments and from nearly 30 global sites. Catalent serves over 1,000 customers and supplies around 70 billion doses annually. Our significant intellectual property includes over 1,400 patents and patent applications. Whether you are looking for a single, tailored solution or multiple answers throughout your product's lifecycle, we can improve the total value of your treatments — from discovery to market and beyond. Catalent. More products. Better treatments. Reliably supplied. ™ Products Tablets • including controlled release and fast dissolve technologies Softgel • 80 years experience of RP Scherer technology • optional enteric coatings • proprietary abuse deterrent technology (OptiGel ™ Lock) • macromolecular encapsulation (OptiGel ™ Bio) • plant derived OptiShell ™ Capsules Facilities Somerset, NJ A manufacturing Center of Excellence for potent molecule handling across Catalent's portfolio of oral solid manufacturing solutions Winchester, KY A state of the art facility for advanced oral controlled-release drug formulation and manufacturing. Winchester has more than 20 years of experience in product development, technology transfer and commercial manufacturing and has produced over 3 billion tablets and capsules annually since its inception Schorndorf, Germany EU manufacturing location for large scale reliable supply of complex controlled release oral solid dose forms through state-of-the-art fluid bed granulation and hot melt extrusion capabilities, integrated development, commercial manufacture and packaging Catalent Pharma Solutions 14 Schoolhouse Road Somerset, NJ 08873 Tel: 732 537 6200 FAX: 732 537 6480 Email: solutions @catalent.com Website: www.catalent.com

Articles in this issue

Links on this page

Archives of this issue

view archives of Tablets & Capsules - TC0615